Showing 1 - 4 results of 4 for search 'Maojin You', query time: 0.04s Refine Results
  1. 1
    Enfortumab vedotin plus pembrolizumab as a first-line treatment for advanced urothelial carcinoma: a cost-effectiveness analysis from China based on the EV-302 trial

    Enfortumab vedotin plus pembrolizumab as a first-line treatment for advanced urothelial carcinoma: a cost-effectiveness analysis from China based on the EV-302 trial by Maojin You, Qiaoyan Zheng, Ying He

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Cost-effectiveness analysis of zolbetuximab plus mFOLFOX6 as the first-line treatment for CLDN18.2-positive, HER2-negative advanced gastric or Gastroesophageal Adenocarcinoma

    Cost-effectiveness analysis of zolbetuximab plus mFOLFOX6 as the first-line treatment for CLDN18.2-positive, HER2-negative advanced gastric or Gastroesophageal Adenocarcinoma by Yufan Huang, Maojin You, Qundan Wu, Ruijia Chen

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Cost-effectiveness analysis of adebrelimab combined with chemotherapy for extensive-stage small cell lung cancer

    Cost-effectiveness analysis of adebrelimab combined with chemotherapy for extensive-stage small cell lung cancer by Maojin You, Ruijia Chen, Qingfeng Wu, Wei Zhu, Ying He, Yufan Huang

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Cost-effectiveness analysis of transarterial chemoembolization combined with lenvatinib as the first-line treatment for advanced hepatocellular carcinoma

    Cost-effectiveness analysis of transarterial chemoembolization combined with lenvatinib as the first-line treatment for advanced hepatocellular carcinoma by Ying He, Wangchun Lin, Zhongjie Cai, Yufan Huang, Maojin You, Meisheng Lei, Ruijia Chen

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: